Answers are grounded in this paper and cite their sources.
The occurrence of somatic mutations in patients with no evidence of hematological disorders is called clonal hematopoiesis (CH). CH, whose subtypes include CH of indeterminate potential and clonal cytopenia of undetermined significance, has been associated with both hematologic cancers and systemic comorbidities. However, CH's effect on patients, especially those with concomitant malignancies, is not fully understood.
No takes yet. Share an insight, caveat, or question.
Chien et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: